As reported by Fu et al., the downregulation of SOX2 and OCT4 expression in advanced HNSCC indicates that SOX2 and OCT4 overexpression noted in initial tumors might decrease gradually during HNSCC progression [102]. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.